Caitong International Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$902 Buy
183
+57
+45% +$306 ﹤0.01% 1570
2026
Q1
$680 Sell
126
-9,932
-99% -$59.4K ﹤0.01% 1553
2025
Q4
$69.9K Buy
10,058
+10,019
+25,690% +$65.9K 0.02% 577
2025
Q3
$252 Sell
39
-824
-95% -$5.63K ﹤0.01% 1641
2025
Q2
$5.75K Sell
863
-3,357
-80% -$17.3K ﹤0.01% 960
2025
Q1
$27.3K Buy
+4,220
New +$30.3K 0.02% 690

Other funds holding BHC

Caitong International Asset Management's BHC Position: Q2 2026 in Review

Caitong International Asset Management increased its Bausch Health (BHC) stake by 45% in Q2 2026, buying an estimated $306 and bringing the position to 183 shares worth $902. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

Caitong International Asset Management first reported a position in BHC in Q1 2025 and has held it in 6 quarters since. The position peaked at $69.9K in Q4 2025. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Caitong International Asset Management held 183 shares of Bausch Health worth $902 as of Q2 2026.
  • Caitong International Asset Management bought 57 Bausch Health shares in Q2 2026, an estimated $306.
  • Bausch Health made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1570 holding.
  • Caitong International Asset Management first reported a position in Bausch Health in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Bausch Health position peaked at $69.9K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.